GE Vernova, Estée Lauder, A Health Care Stock And More On CNBC's 'Final Trades'

On CNBC's “Halftime Report Final Trades,” Bryn Talkington, managing partner of Requisite Capital Management, named AbbVie Inc. (NYSE:ABBV) as her final trade.

On Friday, AbbVie announced a positive CHMP opinion for Maviret to treat acute hepatitis C infection.

Kevin Simpson, co-founder and chief investment officer of Capital Wealth Planning, LLC, picked GE Vernova Inc. (NYSE:GEV) and Archer-Daniels-Midland Company (NYSE:ADM).

On Thursday, GE Vernova signed an agreement to acquire Robotech Automation, a specialized robotics and automation company based near Montreal, Quebec.

Archer-Daniels-Midland reported better-than-expected first-quarter financial results on May 5 and raised its FY26 adjusted EPS guidance, with the midpoint above estimates.

Don't forget to check out our premarket coverage here

Jenny Van Leeuwen Harrington, chief executive officer of Gilman Hill Asset Management, LLC, said Millrose Properties, Inc. (NYSE:MRP) has an 11% dividend yield.

On the earnings front, Millrose Properties reported worse-than-expected first-quarter financial results on May 6.

Stephanie Link, chief investment strategist, head of investment solutions, and portfolio manager at Hightower Advisors, recommended The Estée Lauder Companies Inc. (NYSE:EL).

Estée Lauder shares jumped on Friday after the company announced it terminated discussions regarding a potential business combination with Puig.

Price Action

• AbbVie shares gained 0.6% to close at $215.70 on Friday.
• GE Vernova fell 0.5% to settle at $1,038.74 during the session.
• Archer-Daniels-Midland shares gained 05% to close at $77.52 on Friday.
• Millrose Properties shares rose 0.3% to close at $27.63.
• Estée Lauder shares jumped 11.9% to settle at $88.32 on Friday.

Photo via Shutterstock